These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2793391)

  • 21. Efficacy, safety, and tolerability of ioversol in intra-arterial digital subtraction angiography.
    Miller FJ; Pollei SR; Osborn AG
    Invest Radiol; 1989 Jun; 24 Suppl 1():S52-4. PubMed ID: 2687197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of iopentol in healthy volunteers.
    Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
    Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double blind clinical study comparing the safety, tolerance and efficacy of ioversol 240 and iohexol 240 (Omnipaque 240) in ascending venography.
    Wilkins RA; Spinks BC
    Clin Radiol; 1990 Apr; 41(4):268-71. PubMed ID: 2187651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of iodixanol. A dimeric, nonionic contrast medium: an emphasis on European clinical phases I and II.
    Bolstad B; Borch KW; Grynne BH; Lundby B; Nossen JO; Kloster YF; Kristoffersen DT; Andrew E
    Invest Radiol; 1991 Nov; 26 Suppl 1():S201-4; discussion S208. PubMed ID: 1808130
    [No Abstract]   [Full Text] [Related]  

  • 25. Aortic and pulmonary arterial pressure after injection of contrast media into the right atrium of the rabbit. Comparison between metrizoate, ioxaglate and iohexol.
    Almén T; Aspelin P; Nilsson P
    Acta Radiol Suppl; 1980; 362():37-41. PubMed ID: 6267891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind study comparing the safety, tolerability, and efficacy of ioversol 320 and iopamidol-300 in cerebral angiography.
    Ringel K; Kuehn J
    Invest Radiol; 1989 Jun; 24 Suppl 1():S48-51. PubMed ID: 2687196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacotoxicological profile of a non-ionic LOCM at high hydrophilicity: ioversol].
    Doucet D; Idée JM
    Ann Radiol (Paris); 1992; 35(4 Pt 2):267-72. PubMed ID: 1296489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between chlorpromazine and intrathecally injected non-ionic contrast media in non-anaesthetized rabbits.
    Maly P; Olivecrona H; Almén T; Golman K
    Neuroradiology; 1984; 26(3):235-40. PubMed ID: 6547514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical summary of initial intravenous administration of ioversol.
    McClennan BL
    Invest Radiol; 1989 Jun; 24 Suppl 1():S43-6. PubMed ID: 2687195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iohexol. A non-ionic contrast medium. Pharmacology and toxicology.
    Acta Radiol Suppl; 1980; 362():1-134. PubMed ID: 6267880
    [No Abstract]   [Full Text] [Related]  

  • 31. The blood-brain barrier: effects of nonionic contrast media with and without addition of Ca2+ and Mg2+.
    Golman K
    Invest Radiol; 1979; 14(4):305-8. PubMed ID: 489270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of iohexol in the rat and the isolated rabbit heart.
    Haberey M; Schröder G; Mannesmann G
    Acta Radiol Suppl; 1980; 362():29-35. PubMed ID: 6267890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
    Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
    Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary angiography with iohexol and other contrast media in the dog. I. Electrocardiographic alterations.
    Trägårdh B
    Acta Radiol Suppl; 1980; 362():17-20. PubMed ID: 6267887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of clinical tolerability and diagnostic efficacy of ioversol 350 in UIV. A randomized double-blind study of ioversol 350 versus iohexol 350].
    Voegeli E; Woessmer B
    Ann Radiol (Paris); 1992; 35(4 Pt 2):293-6. PubMed ID: 1296495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hexabrix--a new contrast medium in angiocardiography.
    Cumberland DC
    Br Heart J; 1981 Jun; 45(6):698-702. PubMed ID: 7020727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ioversol 320: a new nonionic, water-soluble contrast medium for body computed tomography clinical trial.
    Kopecky KK; Becker GJ; Conces DJ
    Invest Radiol; 1989 Jun; 24 Suppl 1():S33-4. PubMed ID: 2687192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary study and clinical evaluation method of ioversol in angiocardiography--establishment of safety evaluation parameters and reliability of radiographic quality evaluation].
    Matsuyama S; Kuribayashi S; Ide M; Shigeta A; Umemura J; Harada J; Yamada T; Himi K; Takemoto A; Morimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):620-36. PubMed ID: 2235313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodistribution and excretion of 125I ioversol in conscious dogs.
    Coveney JR; Robbins MS
    Invest Radiol; 1989 Jun; 24 Suppl 1():S23-7. PubMed ID: 2592170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience with ioversol for angiography.
    Bettmann MA
    Invest Radiol; 1989 Jun; 24 Suppl 1():S61-6. PubMed ID: 2687199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.